Whole brain irradiation and intrathecal Methotrexate in the treatment of solid tumor leptomeningeal metastases — A Southwest Oncology Group study
From 1981 through 1985 the Southwest Oncology Group (SWOG) conducted a study evaluating the natural history and the effectiveness of standard therapy in those patients with leptomeningeal carcinomatosis from non-hematologic malignancies. Twenty-six patients were evaluated for the effectiveness of treatment; those who responded to therapy by one month exhibited a median additional survival of 5.7 months and those who were not responders at one month exhibited a median additional survival of 1.8 months. We were unable to identify pre-treatment clinical characteristics which would predict for a favorable response to therapy. Aggressive treatment in some patients may be indicated, as those patients who respond to treatment may have a survival benefit. The overall prognosis in this patient group remains exceedingly poor.
Key wordsleptomeningeal carcinomatosis intrathecal methotrexate whole brain irradiation
Unable to display preview. Download preview PDF.
- 5.Hitchins RN, Bell DR, Woods RL, Levi JA: A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clinic Oncol 5(10):1655–1662, 1987Google Scholar
- 6.Giannon L, Greco Fa, Hainsworth JD: Combination intraventricular chemotherapy for meningeal neoplasia. J of Clin Oncol 4(1):68–73, 1986Google Scholar
- 9.Bleyer WA: Current status of intrathecal chemotherapy for human meingeal noeplasms. HEW, NIH, National Cancer Institute Monograph 46:171–178, 1977Google Scholar
- 11.Gutin PH, Levi JA, Wiernik PH, Walker MD: Treatment of malignant meningeal disease with intrathecal ThioTEPA — A Phase II study. Cancer Treatment Reports (HEW, NIH, NCI) 61(5):885–887, 1977Google Scholar
- 12.Kun LE, Pinkel D: Miningeal leukemia — control versus cure. Int J Rad Oncol, Biol, Phy 2:371–373, 1977Google Scholar